Oppenheimer Downgrades Raptor Pharmaceutical To Underperform

By: via Benzinga
Analysts at Oppenheimer downgraded Raptor Pharmaceutical Corp. (NASDAQ: RPTP) from Perform to Underperform. Raptor Pharmaceutical ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.